
71.51 Delayed Data As of Mar 04 | ![]() Today’s Change | 32.95 Today|||52-Week Range 90.19 | -6.92% Year-to-Date |
Arena (ARNA) Tumbles as Mid-Stage Gastrointestinal Study Fails Mar 03 / Zacks.com - Paid Partner Content | Arena Pharmaceuticals Inc (ARNA) Q4 2020 Earnings Call Transcript Feb 24 / MotleyFool.com - Paid Partner Content |
Arena (ARNA) Q4 Earnings Miss Estimates, Pipeline Progresses Feb 24 / Zacks.com - Paid Partner Content | Drug/Biotech Stock Q4 Earnings on Feb 23: JAZZ, ARNA & More Feb 22 / Zacks.com - Paid Partner Content |
Previous close | 73.26 |
Today’s open | 73.13 |
Day’s range | 70.86 - 74.56 |
Volume | 1,079,346 |
Average volume (3 months) | 651,617 |
Market cap | $4.9B |
Earnings growth (last year) | -192.53% |
Earnings growth (this year) | -14.84% |
Earnings growth (next 5 years) | -96.93% |
Revenue growth (last year) | -99.96% |
P/E ratio | NM |
Price/Sales | 13,190.40 |
Price/Book | 4.36 |
Today’s change | Today’s % change | |
---|---|---|
SAGESAGE Therapeutics In... | -5.52 | -7.25% |
HCMHutchison China Medi... | -2.15 | -7.16% |
CCXIChemoCentryx Inc | -5.15 | -8.26% |
CBPOChina Biologic Produ... | +0.06 | +0.05% |
Next reporting date | May 11, 2021 |
EPS forecast (this quarter) | -$2.16 |
Annual revenue (last year) | $319.0K |
Annual profit (last year) | -$404.7M |
Net profit margin | -126,875.86% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |